![New Clinical Guidelines: Distinguishing Variations of Progressive Supranuclear Palsy - Neurology Advisor New Clinical Guidelines: Distinguishing Variations of Progressive Supranuclear Palsy - Neurology Advisor](https://www.neurologyadvisor.com/wp-content/uploads/sites/10/2018/12/progressivesupranuclearpalsy_1227568.jpg)
New Clinical Guidelines: Distinguishing Variations of Progressive Supranuclear Palsy - Neurology Advisor
![PDF] Exodeviated Ophthalmoplegia in a Patient with Progressive Supranuclear Palsy | Semantic Scholar PDF] Exodeviated Ophthalmoplegia in a Patient with Progressive Supranuclear Palsy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/70f03e74533fb7ca79fc1e8c9eb175daa3c0d18a/2-Figure1-1.png)
PDF] Exodeviated Ophthalmoplegia in a Patient with Progressive Supranuclear Palsy | Semantic Scholar
![Frontiers | Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism Frontiers | Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism](https://www.frontiersin.org/files/MyHome%20Article%20Library/804385/804385_Thumb_400.jpg)
Frontiers | Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism
![Cureus | Progressive Supranuclear Palsy: Improvement in Cognitive-Behavioral Disturbances and Motor-Function Disabilities Following Treatment With Antidepressants and Cholinesterase Inhibitors Cureus | Progressive Supranuclear Palsy: Improvement in Cognitive-Behavioral Disturbances and Motor-Function Disabilities Following Treatment With Antidepressants and Cholinesterase Inhibitors](https://assets.cureus.com/uploads/figure/file/212710/lightbox_aa4b7b40b1e611eb90a7718fc86ee1e6-Figure-1_900-revised.png)
Cureus | Progressive Supranuclear Palsy: Improvement in Cognitive-Behavioral Disturbances and Motor-Function Disabilities Following Treatment With Antidepressants and Cholinesterase Inhibitors
![PDF] Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges | Semantic Scholar PDF] Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1135e4c1f219c17aa9ce003c7b1457eb52830208/2-Figure2-1.png)
PDF] Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges | Semantic Scholar
![Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges - ScienceDirect Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1474442209700420-gr1.jpg)
Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges - ScienceDirect
![Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches - The Lancet Neurology Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches - The Lancet Neurology](https://www.thelancet.com/cms/attachment/2100712427/2079660437/gr1.jpg)